New RotoRepel™ Rx Nonstick Treatment Now Available

The industry’s top no-stick treatment now offers expanded performance benefits for the medical and pharmaceutical industry. The new RotoRepel™ Rx treatment offers the same exclusive nonstick and press performance benefits of our original RotoRepel™ treatment, now with an FDA Master File.

To earn this FDA Master File, RotoRepel™ Rx underwent a US Food and Drug Administration regulatory compliance review, migration testing and toxicological safety assessment. RotoRepel™ Rx is safe for intended use in conversion of parts, devices and labels.

RotoRepel™ and RotoRepel™ Rx will dramatically shift your expectations of a nonstick treatment. With RotoRepel™ and RotoRepel™ Rx, there’s no chipping or flaking like you might experience with other nonstick coatings. The RotoRepel™ line of treatments are unmatched in durability and performance and offer significant reduction in press shutdown for cleaning and maintenance, with many users reporting saving at least an hour per shift. This is due to the improved reduction of adhesive buildup across all adhesive types and abrasive materials. The treatment also results in less die damage due to dies being handled less often, increasing die longevity. RotoMetrics is also a 2018 finalist for the Award for Innovation from the Label Industry Global Awards for the RotoRepel™ and RotoRepel™  Rx line.

The formulation for RotoRepel™ Rx nonstick rotary die treatment has undergone a US Food and Drug Administration regulatory compliance review, migration testing, and toxicological safety assessment. RotoRepel™ Rx is safe for intended use in conversion of parts, devices and labels. Additionally, RotoRepel™ Rx is compliant with US FDA food contact regulations. RotoRepel™ Rx is filed with the US Food and Drug Administration under Master File for Devices (MAF) #2975. View the full press release.

For more details and ordering information, contact a RotoMetrics representative today. To view more exceptional products from RotoMetrics, click here.

SHARE